ViGenCell Inc. (KOSDAQ: A308080)
Health Care · Biotechnology · KR
₩5,840.00
+0.52% today · +71.0% 1Y
ViGenCell Inc. (KOSDAQ: A308080) operates in the Biotechnology industry within the Health Care sector. The company is valued at $89.05M.
Over the last twelve months the share price has gained 71.0%, trading between 3.07K and 17.36K.
Tweenvest scores ViGenCell Inc. across four factors: quality 50/100, value 69/100. Its strongest factor is value.
A308080 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $89.05M
- Revenue (TTM)
- $189.41K
- P/E
- —
- EPS
- -650.72
- Dividend yield
- —
- Beta (5Y)
- 1.79
- 52-week high
- ₩17,360.00
- 52-week low
- ₩3,070.00
- Avg volume (3M)
- —
- Shares outstanding
- 20.50M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cellectis S.A.ENXTPA: ALCLS | $92.50M | €1.14 | +0.98% |
| Dimerix LimitedASX: DXB | $92.18M | AU$0.22 | -2.22% |
| Rallybio CorporationNasdaqCM: RLYB | $90.38M | $16.93 | -0.53% |
| Equillium, Inc.NasdaqCM: EQ | $89.41M | $1.40 | -1.06% |
| ImmuCell CorporationNasdaqCM: ICCC | $89.01M | $10.50 | +7.14% |
| Citius Oncology, Inc.NasdaqCM: CTOR | $88.82M | $0.77 | -8.31% |
| Bonraybio Co., Ltd.TWSE: 6955 | $88.36M | NT$93.00 | -0.53% |
| Y-Biologics, Inc.KOSDAQ: A338840 | $87.21M | ₩7,630.00 | -10.45% |
Figures last refreshed Oct 11, 2026.